Archive for August 2020
Neurolief Wins FDA Breakthrough Device Designation for Wearable Neuromod for Depression
Neurolief, a medical neurotechnology innovator, today announces that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Relivion system, the first non-invasive multi-channel brain neuromodulation technology, for the treatment of major depression. A wearable device, the Relivion system is designed as an adjunctive treatment to pharmaceutical management of major depressive disorder…
Read MoreeSight 4 Earns CE Mark Approval to Bring New Wearable Device to Europe
eSight, a cutting-edge vision enhancement platform, today announces it has received CE Mark approval for eSight 4, the company’s latest assistive technology device that’s clinically proven to significantly enhance vision for those living with low vision and legal blindness. The CE Mark certification signifies that eSight 4 has been assessed to meet high safety, health…
Read MoreFDA Clears Life Spine Anterior Lumbar Spacer System
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the PLATEAU-A Ti Anterior Lumbar Spacer System. “With the increased usage of anterior column reconstruction, PLATEAU-A Ti fills…
Read MoreEko and AstraZeneca Announce Digital Cardiovascular Health Partnership
Eko today announced a global collaboration with AstraZeneca to accelerate the development of digital health tools for the earlier screening of cardiovascular diseases, including heart failure. “There are millions of people living with or at risk for heart failure. AstraZeneca’s collaboration with Eko will tap into cutting-edge digital health technologies that could allow us to…
Read MoreSiemens Healthineers to buy Varian Medical Systems for $16.4 billion
Varian today announced that it has entered into a definitive agreement to combine with Siemens Healthineers AG in an all-cash transaction valued at $16.4 billion on a fully diluted basis. Under the terms of the agreement, which has been unanimously approved by Varian’s Board of Directors, Siemens Healthineers will acquire all outstanding shares of Varian…
Read More